CPHI Milan 2
CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
The Future of Pharmaceutical Manufacturing
Editorial Archive

The Future of Pharmaceutical Manufacturing

According to a recent survey, global annual spending on pharmaceuticals is set to reach almost 1.2 trillion US dollars in 2016. The so-called pharmerging markets ...
Continue Reading →
Disposable Filling Needles
Editorial Archive

Disposable Filling Needles

For many years, biopharmaceutical production processes have been characterised by the cleaning and autoclaving processes of the existing systems, usually made of ...
Continue Reading →
Clinical Supply in Emerging Markets
Editorial Archive

Clinical Supply in Emerging Markets

Over the last few years there has been a shift in conducting clinical trials away from North America and Europe and towards emerging markets, particularly the B...
Continue Reading →
Ambient Temperature Profile Development: A New Approach for Qualifying and Defining a Shipping System’s Performance
Editorial Archive

Ambient Temperature Profile Development: A New Approach for Qualifying and Defining a Shipping System’s Performance

When developing an ambient profile for a temperature-controlled packaging solution to be qualified against, every temperature- controlled packaging (TCP) user h...
Continue Reading →
Patient Recruitment Driving Length and Cost of Oncology Clinical Trials
Clinical Research V5 I2

Patient Recruitment Driving Length and Cost of Oncology Clinical Trials

As prospective oncology drugs progress from Phase I to Phase III clinical trials, the difference between projected and actual patient enrollment durations typic...
Continue Reading →
Photostability Testing: Shedding Light on a Not Well Understood Guideline
Clinical Research V5 I2

Photostability Testing: Shedding Light on a Not Well Understood Guideline

The subject of pharmaceutical photostability testing often raises many questions for several reasons. Predominantly governed by ICH Guideline Q1B for small mole...
Continue Reading →
The Benefits of Bacillus-derived Hyaluronic Acid
Drug Discovery, Development & Delivery V5I2

The Benefits of Bacillus-derived Hyaluronic Acid

In Adding New and Improved Attributes to Existing Drug Formulations, and Offering Opportunities for New Delivery System Development Jaypreet Dhillon, Editorial Ma...
Continue Reading →
Preactivated Thiomers: A New Generation of Mucoadhesive Polymers
Drug Discovery, Development & Delivery V5I2

Preactivated Thiomers: A New Generation of Mucoadhesive Polymers

Since the concept of mucoadhesion was pioneered in the early 1980s, various attempts have been made to improve the adhesive properties of polymers. These attemp...
Continue Reading →
Optimising Short-Lived Isotopes for Quantitative Whole-Body Autoradiography in Drug Development
Drug Discovery, Development & Delivery V5I2

Optimising Short-Lived Isotopes for Quantitative Whole-Body Autoradiography in Drug Development

Quantitative whole-body autoradiography (QWBA), which has brought many improvements to the realm of tissue distribution, has itself been improved recently by the ...
Continue Reading →
Virtual Drug Development: Vision, Oversight and Risk Management
Drug Discovery, Development & Delivery V5I2

Virtual Drug Development: Vision, Oversight and Risk Management

The previous article examined how drug development has changed over the last century, whilst highlighting the theme of the increased complexity of drug developm...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026